 |
|
|
 |
VOLUME 34: NO. 5 MAY 2007 Editorials
Genetic Association Studies in Systemic Sclerosis: More Evidence of a Complex Disease
Time to Expand Our Horizons Regarding Real-Life Studies of Self-Management and Psychosocial Outcomes
Entertaining Patients and Dazzling Reviewers
•
A Pain Psychologist's View of Tenderness in Fibromyalgia
The Fibromyalgia Tender Points: Use Them or Lose Them? A Brief Review of the Controversy
•
Catastrophic Antiphospholipid Syndrome and Sepsis.
A Common Link?
Articles
Macrophage Migration Inhibitory Factor Upregulates Angiogenic Factors and Correlates with Clinical Measures in RA
Differences in Atherosclerotic Coronary Heart Disease Between Subjects with and without RA
Influence of Nonclassical CV Risk Factors on the Accuracy of Predicting Subclinical Atherosclerosis in RA
Response to Pneumococcal Vaccine in Patients with Early RA Receiving Infliximab plus MTX or MTX Alone
Determining Rheumatologists' Accuracy at Assessing Functional Disability in RA Patients Using the HAQ-DI
Beneficial Action of Statins in Patients with RA in a Large Observational Cohort
Soluble CD154 Is Not Associated with Atherosclerosis in SLE
Screening for Proteinuria in Patients with Lupus:
A Survey of Practice Preferences Among American Rheumatologists
Measurement of ANA by Multiplex Immunoassay:
A Prospective, Multicenter Clinical Evaluation
Assessment of Damage in Korean Patients with SLE
Incidence of Postpartum Thrombosis and Preterm Delivery in Women with aPL and Recurrent Pregnancy Loss
Association of Polymorphisms in the IL1B and IL2 Genes with Susceptibility and Severity of SSc
Prevalence and Characteristics of Moderate to Severe Pulmonary Hypertension in SSc with and without ILD
Clinical Evaluation of Anti-ARS Antibodies in Japanese Patients with DM
TLR in Salivary Glands from Patients with SS: Functional Analysis by Human Salivary Gland Cell Line
AECA in Patients with WG: Prevalence and Correlation with Disease Activity and Manifestations
The Influence of Illness and Variables Associated with Functional Limitations in Chinese Patients with AS
Safety and Efficacy of Adalimumab in Treatment of Patients with PsA Who Had Failed DMARD Therapy
Prevention of Glucocorticoid Induced Osteoporosis with Alendronate or Alfacalcidol: Relations of Change in BMD, Bone Markers, and Calcium Homeostasis
The Synthetic Triterpenoid TP-222 Inhibits RANKL Stimulation of Osteoclastogenesis and MMP-9 Expression
"Keep on Truckin'" or "It's Got You in This Little Vacuum": Race-Based Perceptions in Decision-Making for TKA
Hand Dominance in Upper Extremity MSK Disorders
Conservative Management of Mechanical Neck Disorders: A Systematic Review
A Combination of 6 Months of Treatment with Pyridostigmine and Triweekly Exercise Fails to Improve IGF-I Levels in FM, Despite Improvement in the Acute GH Response to Exercise
Does Self-Management Lead to Sustainable Health Benefits in People with Arthritis? A 2-year Transition Study of 452 Australians
•
Meeting Report 2006 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN)
Pediatric Rheumatology
Amitriptyline to Relieve Pain in JIA: A Pilot Study
Using Bayesian Metaanalysis of Multiple
N-of-1 Clinical Trials
Occult MAS in Patients with Systemic JIA
Prevalence and Outcome of JIA-Associated Uveitis and Relation to Articular Disease
TNF-a Blocker in Treatment of JIA-Associated Uveitis Refractory to Second-line Agents: Results of a Multinational Survey Case Report
Acute Exacerbation of Preexisting ILD After Administration of Etanercept for RA
Images in Rheumatology
Dactylitis of the Thumb and the Little Finger
Extending to the Carpal Tunnel
SpA as a Presentation of Gouty Arthritis
OMERACT 8 International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials, St. Julian's Bay, Malta, May 10-14, 2006 Outcome Measures
Outcome Measures in PsA
Consensus on a Core Set of Domains for PsA
Patient Perspective: Reasons and Methods for Measuring Fatigue in RA
Patient Perspective: Fatigue as a Recommended Patient Centered Outcome Measure in RA
Considerations and Preliminary Proposals for Defining a Reference Case for Economic Evaluations in AS
Rationale and Strategies for Reevaluating the ACR20
Minimal Clinically Important Improvement and Patient Acceptable Symptom State for Subjective Outcome Measures in Rheumatic Disorders
SSc — Continuing Progress in Developing Clinical Measures of Response
Correspondence
Techniques for "Blind" Glucocorticosteroid Injections into Glenohumeral Joints
Reply
Meetings in Rheumatology
|
